Posters and Presentations

Each year, the ARUP Institute for Clinical and Experimental Pathology® presents at more than 200 conferences, workshops, annual meetings, and symposiums for several national and international organizations. Recent posters and presentations are listed below.

Request a poster.

JUNE 2017

ASM Microbe
New Orleans, LA, June 1–5, 2017

Hanson KE, Slechta ES—Poster
Body BA, Beard M, Hanson KE, Rychert J, Slechta ES, Barton L, Cantrell C, Babady NE, McMillen TA, Tang TW, Brown-Elliott BA, Lakhiaeva E, Vasireddy R, Vasireddy S, Smith T, Wallace J, Butley-Wu SM, Curtis L, Turner S. Performance of the new bioMerieux VITEK® MS v3.0* database for identification of mycobacterium and nocardia.

Hanson KE, Slechta ES—Poster
Bradford C, Pincus DH, Hanson KE, Rychert J, Slechta ES, Beard M, Body B, Babady NE, Miranda E, Tang YW, Sutton DA, Wiederhold NP, Butler-Wu SM, Curtis L, Turner S. Reproducibility of the new bioMerieux VITEK® MS v3.0* database for identification of moulds, mycobacterium, and nocardia.

Slechta ES, Barker AP, Hanson KE—Poster
Rychert J, Slechta ES, Barker AP, Miranda E, Babady NE, Tang YW, Wiederhold NP, Sutton DA, Hanson KE. Multi-center evaluation of the VITEK® MS v3.0 MALDI-TOF mass spectrometry system for the identification of medically important moulds.

American Society for Mass Spectrometry (ASMS)
Indianapolis, IN, June 4–8, 2017

Ray JA, Straseski JA—Poster
Ray JA, Straseski JA. Trimester-specific progesterone reference intervals established in human serum/plasma using a fast LC-MS/MS method coupled with differential ion mobility spectrometry.

MAY 2017

International Society for Laboratory Hematology (ISLH)
Honolulu, HI, May 4–6, 2017

Heikal N, Martins TB, Tebo AE—Poster
Heikal N, Martins TB, Miller J, Tebo AE. Antibodies to domain I of beta2 glycoprotein I in an at-risk cohort for antiphospholipid syndrome.

Ravkov E, Salama M, Longhurst M, Andersen E, Heikal N—Presentation
Ravkov E, Salama M, Longhurst M, Andersen E, Heikal N. Validation and evaluation of telomere length-flow FISH assay in patients with myelodysplastic syndrome.

Crist RA, Heikal NM, Rodgers GM, Grenache DG, Smock KJ—Poster
Crist RA, Heikal NM, Rodgers GM, Grenache DG, Kunzler TM, Choi MA, Smock KJ. Evaluation of a new commercial method for vonWillebrand factor multimeric analysis.

Liew M, Rowe LR, Szankasi P, Paxton CN, Salama ME—Poster
Liew M, Rowe LR, Szankasi P, Paxton CN, Salama ME. Validation of BCL6 (3q27) rearrangement using digital FISH and characterization of unusual patterns using SNP array platform and next-generation sequencing.

Clinical Virology Symposium (CVS)
Savannah, GA, May 7–10, 2017

Mallory MA, Hillyard DR—Poster
Mallory MA, Hillyard DR. Detection of HCV genotype 1 NS5A resistance-associated variants by Sanger sequencing.

Pyne MT, Mallory MA, Hillyard DR—Poster
Pyne MT, Ormonde-Hansen P, Mallory MA, Chumley J, Winters MA, Rychert J, Mauck K, Bartel P, Hillyard DR. Development and validation of a dual-targeted quantitative realtime RT-PCR assay for hepatitis delta virus (HDV).

Hymas WC, Hillyard DR—Poster
Hymas WC, Hillyard DR. Comparison of 2nd and 4th generation multiplex real-time RT-PCR assays for influenza A, influenza B, and RSV detection.

Elgort M, Hillyard D—Poster
Elgort M, Hillyard D. Comparison of multiple secondary BKV standard panels to the WHO 1st international BKV standard on the Elite Ingenius sample to result platform.

Pediatric Rheumatology Symposium (PRSYM)
Houston, TX, May 17–20, 2017

Tebo A—Poster
Taneja A, Hersh A, Ponder L, Chan LHK, Rouser-Stevens K, Tebo A, Guthery S, Kugathasan S, Bonhnsack J, Prahalad S. Prevalence of celiac antibodies and IgA deficiency in juvenile idiopathic arthritis.

APRIL 2017

Endocrine Society (ENDO)
Orlando, FL, April 1–4, 2017

Wyness SP, Straseski JA—Poster
Wyness SP, Prust L, Christenson R, Straseski JA. Easy as 1, 2, 3? Trimester-specific TSH reference intervals in a well-characterized population using the Beckman Coulter 3rd IS immunoassay.

Straseski JA—Presentation
Straseski JA. Clinicians beware! Myths and realities of interpreting reference intervals.

American Academy of Neurology (AAN)
Boston, MA, April 22–28, 2017

Tebo A, Haven T—Poster
Sweeney M, Galli J, McNally JS, Tebo A, Haven T, Thulin P, Clardy SL. The controversy surrounding voltage-gated potassium channel (VGKC)-complex antibodies: case and discussion.

MARCH 2017

United States and Canadian Academy of Pathology (USCAP)
San Antonio, TX, March 4–10, 2017

Patel JL, Schumacher JA, Kelley TW—Presentation
Patel JL, Schumacher JA, Frizzell K, Sorrells S, Shen W, Clayton A, Jattani R, Kelley TW. Coexisting and cooperating mutations in NPM1-mutated AML.

Matynia A, Li D, Schumacher JA, Szankasi P, Kelley TW—Poster
Matynia A, Li D, Schumacher JA, Szankasi P, Kelley TW. “Molecular fingerprinting” of anatomically and temporally distinct B-cell lymphoma samples by next generation sequencing to establish clonal relatedness.

Salama M, Patel J, Agarwal AM—Poster
Cunningham AM, Salama M, Patel J, Agarwal AM. Phenotypic trends within genomic classifications of acute myeloid leukemia.

Tripp S, Reading NS, Salama M, Miles R—Poster
Soto LR, Glenn MJ, Tripp S, Reading NS, Salama M, Miles R. CD30 expression by RNA level but not by PAX5/CD30 double stain is associated with worse outcomes in diffuse large B-cell lymphoma.

American College of Medical Genetics and Genomics (ACMG)
Phoenix, AZ, March 21–25, 2017

Andersen EF, Toydemir R, Hong B—Poster
Paulraj P, Diamond S, Razzaqi F, Ozeran F, Andersen EF, Toydemir R, Hong B. Three pediatric acute myeloid leukemia patients with t(7;21)(p22;q22) and utility of genomic microarray analysis in detecting additional clonal aberrations.

Toydemir R—Poster
Paulraj P, Palumbos J, Openshaw A, Carey J, Toydemir R. Interstitial deletion 6q25.2q26 associated with severe phenotypic features, congenital anomalies and global developmental delay.

Yuzyuk T, De Biase I—Poster
Gasparini J, Ortega A, Yuzyuk T, De Biase I. Perceived self-efficacy of genetic counselors as teachers.

Pham H, Pont-Kingdon G, Lyon E—Poster
Poster Brown S, Pham H, Pont-Kingdon G, Lyon E. Additional testing can aid interpretation of SMN1 and SMN2 copy number for patients with gene conversions.

Ha Y, Pham HT, Pont-Kingdon G, Lyon E—Poster
Poster Ha Y, Pham HT, Sibio S, Monds C, Pitchford J, Braten B, Meadows C, Miller C, Pont-Kingdon G, Lyon E. Implementation of the cystic fibrosis 165-pathogenic variant panel by QuantStudio™ 12K Flex OpenArray®.

Millson A, Morris AD, Paul EG, Lamb AN, Lyon E—Poster
Poster Millson A, Xiong W, Mikelson A, Morris AD, Paul EG, Lachowsky DR, LaGrave D, Lamb AN, Lyon E, Kusukawa N. Noninvasive prenatal testing for aneuploidy.

Andersen EF—Poster
Poster Herriges JC, Brown S, Ozmore J, Janze A, Meck J, Andersen EF. The first clinical reports of 14q32 deletions that encompass DICER1 and are associated with DICER1-related tumor development.

Clinical Immunology Society (CIS)
Seattle, WA, March 23–26, 2017

Close DW, Kumánovics A—Poster
Patel B, Niebur H, Grana NH, Berman DM, Tuite GF, Close DW, Kumánovics A, Leiding JW. Evolution of immunodeficiency in a patient with kabuki syndrome.

Close DW, Kumánovics A—Poster
Sriaroon P, Chang Y, Ujhazi B, Csomos K, Joshi H, Zhou Q, Close DW, Armanios M, Walter JE, Kumánovics A. Thrombocytopenia as initial presentation of ikaros deficiency associated with a novel IKZF1 mutation.

FEBRUARY 2017

Park City Anatomic Pathology Update
Park City, UT, February 6–10, 2017

Smock KJ—Presentation
Smock KJ. Update on anticoagulants monitoring practice.

JANUARY 2017

Mass Spectrometry: Applications to the Clinical Lab (MSACL)
Palm Springs, CA, January 22–26, 2017

Ray JA, Rasmussen N, Strathmann FG—Poster
Ray JA, Golsan H, Rasmussen N, Strathmann FG. A proposed strategy for the detection of metabolic disorders: high resolution screening with reflex to targeted quantitation by tandem mass spectrometry.

Kushnir MM, Strathmann FG—Poster
Kushnir MM, Strathmann FG. A new look at parathyroid hormone-related protein (PTHrP): possible role for calcium regulation in brain.

Kushnir MM, Rockwood AL—Poster
Hattan SJ, Parker KC, Vestal ML, Kushnir MM, Rockwood AL. Large-scale study of glycated hemoglobin levels using dried blood spots and MALDI-TOF mass spectrometry.

Song B, Frank E—Poster
Song B, Frank E. Development and validation of a high-throughput quantitative method for determination of vitamin B6 in serum and plasma using LC-MS/MS.

Parker RL, Strathmann FG—Poster
Parker RL, Strathmann FG. Development of a twelve element panel in urine using an automated, 96-well based ICP-MS workflow.

Merrigan SD, Johnson-Davis KL—Poster
Merrigan SD, Powers JL, Johnson-Davis KL. LC-MS/MS method for quantitative analysis of clozapine, its major metabolites (norclozapine and clozapine N-oxide), and trazodone in serum or plasma.

Clark ZD, Barker A, Strathmann FG—Poster
Clark ZD, Barker A, Strathmann FG. Intelligent design of a toxicology panel: let chemistry be your guide.

American Federation for Medical Research: Western Medical Research Conference (AFMR-WMRC)
Carmel, CA, January 26–28, 2017

Martins TB, Slev PR, Hill HR—Poster
Martins TB, Wilcock DM, Firszt R, Slev PR, Hill HR. Evaluation of a basophil activation flow cytometric assay as an alternative to oral food challenge for determining peanut allergy.

DECEMBER 2016

American Society of Hematology (ASH)
San Diego, CA, December 3–6, 2016

Reading NS—Poster
Shah BN, Thuma PE, Reading NS, DelBove J, Prchal JT, Gordeuk VR. Host genetic factors in glucose-6-phosphate dehydrogenase and cytochrome b5 reductase 3 affect the susceptible of developing severe malarial anemia.

Agarwal AM, Reading NS, Salama ME, Patel JL—Poster
Agarwal AM, Reading NS, Frizzell K, Shen W, Sorrells S, Salama ME, Patel JL. Novel mutations identified in inherited bone marrow failure syndromes by next-generation sequencing.

Agarwal AM, Reading NS, Salama M, Patel JL—Poster
Agarwal AM, Reading NS, Kimberly F, Shen W, Sorrells S, Salama M, Prchal J, Yaish H, Patel JL, Christensen R. Insight into molecular basis of hemolytic anemia.

Reading NS, Agarwal AM, Salama ME—Poster
Reading NS, Agarwal AM, Hoffman R, Prchal JT, Salama ME. Transcriptional characterization of myelofibrotic bone marrow microenvironment reveals distinct tumor microenvironment in JAK2+ and CALR+ PMF marrows.

Miles RR—Poster
Miles RR. Microrna (miR)-17-92 contributes to therapy resistance in Burkitt lymphoma cells.